2025. Molecular Mechanisms of FDA-Approved Drugs for the Treatment of Alzheimer’s Disease: A Comprehensive Review. Molecular Medicine Communications. 5, 1 (Jun. 2025), 17–28. DOI:https://doi.org/10.55627/mmc.005.01.01795.